Exagen Inc - XGN Net Assets per Single Share

Graphic logo of Exagen (XGN)

Exagen Inc. (XGN) specializes in laboratory diagnostics and pathology detection. This price chart illustrates the asset's dynamics, with a value of 0.50. The business relies on eco-friendly paperless documentation and sustainable waste recycling. The company's efficiency is supported by a streamlined express transport network for delivering biomaterials to research centers via reliable courier partners, ensuring high order processing speeds.

XGN: Exagen Diagnostics Net Asset Value per Share 07/04/2022 - 10/28/2026

Exagen Inc - analytical breakdowns and key metrics (XGN)

- price and consensus price forecast:
Price Chart Exagen Diagnostics|XGN - Broker Consensus Forecast
- market capitalization data:
Market Value Exagen|XGN - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Exagen Inc.|XGN - Total Stockholders' Equity|Market Capitalization to Book Value Ratio exagen.com|XGN - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Exagen Inc.|XGN - Long-Term Debt to Capital|Short-Term Debt to Equity Exagen Diagnostics|XGN - Company Aggregate Debt|Debts to Book Capitalization Exagen
Analysis of all company metrics:exagen.com (XGN)
Manufactured products of Exagen Diagnostics

This indicator reflects the residual value of net assets per share, representing the difference between the issuer's total assets and liabilities. By analyzing the book value per share under IFRS, an investor assesses the intrinsic value of the business, which for Exagen Inc. (XGN) is supported by efficient diagnostic test logistics management and the optimization of the warehouse network, directly impacting asset capitalization.

Competitor analysis for Exagen Inc.

Agilent Tech (A) - Net Assets per Single Share|DGX: Equity per Share|ILMN (Illumina, Inc.) - Net Assets per Single Share|exactsciences.com (EXAS) - Accounting Value per Share|Book Value per Share RVTY (Revvity)|Net Asset Value per Share Bio-Rad Laboratories, Inc.|Book Value per Share Anbio Tech NNNN|Equity per Share Nordion (SHC)|Book Value per Share QDEL (QuidelOrtho)|opko.com - Book Value per Share|CareDx, Inc (CDNA) - Net Assets per Single Share|MRVI - Equity per Share|FLGT: Book Value per Share|LAB (Standard BioTools Corp) - Book Value per Share|Net Assets per Single Share Cytek Biosciences, Inc.|Net Assets per Single Share orasure.com (OSUR)|MDxHealth - Accounting Value per Share|Net Asset Value per Share LUCD (Lucid Diagnostics, Inc.)|Net Assets per Single Share PRE|Net Assets per Share Insight Molecular Diagnostics, Inc. IMDX|Book Value per Share TRIB (Trinity Biotech Corp)|PRPH: Net Assets per Share|Ainos - Net Assets per Single Share|Co-Diagnostics Inc (CODX) - Net Assets per Share|Book Value per Share HSCS (Heart Test Laboratories Inc.)|Net Asset Value per Share Biomerica Inc (BMRA)|Accounting Value per Share Cardio Diagnostics CDIO|Equity per Share viraxbiolabs.com (VRAX)|Book Value per Share BJDX (Bluejay Diagnostics, Inc.)|Book Value per Share Aspira Women's Health, Inc. AWH|Book Value per Share AXDX|CNTG - Book Value of One Share|Book Value per Share ENZ|FRES (Fresh2 Group) - Net Asset Value per Share|Net Assets per Single Share Genetic Technologies Ltd (GENE)|Equity per Share 23andMe Holding Co (ME)|Psychemedics Corp (PMD) - Accounting Value per Share